# Progress Note 01 — Initial plan

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Sun Yat-sen (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-ET016-SYN
- Date: 2026-05-04
- Fictional facility: St. Posthumous Health Center
- Fictional author: Wen-Li Huang, MD
- Calendar frame: modern shifted

## Subjective

The patient participates in this fictional visit for new patient with a right upper abdominal mass, aching and weight loss: work-up of a liver mass, symptom care, and how he wants to receive results. **S**

## Objective

White cells: 7.9 10*3/uL; Hemoglobin: 12.6 g/dL (low); Platelets: 342 10*3/uL; Sodium: 137 mmol/L; Potassium: 4.2 mmol/L; Creatinine: 0.86 mg/dL; eGFR: 101 mL/min/1.73 m²; Glucose: 98 mg/dL; Albumin: 3.4 g/dL (low); Total bilirubin: 0.9 mg/dL; Alkaline phosphatase: 212 U/L (high); AST: 48 U/L (high); ALT: 41 U/L; INR: 1; Alpha-fetoprotein: 3.2 ng/mL; CA 19-9: 412 U/mL (high); CEA: 8.6 ng/mL (high); PHQ-2: 1; ECOG performance status: 1. All results are synthetic.

BP 132/84 mmHg; pulse 88 bpm; respirations 16/min; temperature 36.9 °C; oxygen saturation 98% on room air; weight 61 kg; BMI 22.4 kg/m². All vital signs are synthetic.

## Assessment

Active problems: Right upper quadrant abdominal mass with weight loss: a dull ache under the right ribs and early fullness for about three months, 4 kg weight loss, and a firm, non-tender mass felt 4 cm below the right costal margin; no jaundice, fever, or itching. Ultrasound today: a 6.8 cm solid, heterogeneous mass in liver segments IV and V that cannot be separated from the gallbladder, which contains stones; the rest of the liver is smooth, with no ascites. Multiphase CT, tumor markers, hepatitis serology and medical oncology consultation arranged. Strengths and supports remain part of the care plan. **S**

## Medication changes

- Started: Acetaminophen 500 mg oral tablet, two tablets by mouth every 8 hours as needed for right upper abdominal ache; no more than 3,000 mg a day **S**

## Plan

- Work-up of the liver mass: multiphase contrast CT of the liver with CT of the chest, abdomen and pelvis; MRI of the liver with MRCP if CT does not settle the origin; alpha-fetoprotein, CA 19-9 and CEA; hepatitis B surface antigen, core antibody and surface antibody, and hepatitis C antibody; liver function with Child-Pugh and ALBI scoring; and image-guided core biopsy, because a mass in a liver without cirrhosis cannot be diagnosed by imaging alone. Guideline: NCCN Clinical Practice Guidelines in Oncology: Biliary Tract Cancers (2026); AASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma (2023) **S**
- Medical oncology consultation for a solid liver mass with weight loss: diagnosis, staging, multidisciplinary tumor board review, and treatment. Guideline: NCCN Clinical Practice Guidelines in Oncology: Biliary Tract Cancers (2026); AASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma (2023) **S**
- Symptom care during the work-up: acetaminophen up to 3,000 mg a day, small frequent meals with a dietitian's advice, weight at every visit, and a same-day call for jaundice, fever, vomiting, dark urine or worse pain; results shared with him in full as they arrive, by one coordinating clinician. Guideline: NCCN Clinical Practice Guidelines in Oncology: Biliary Tract Cancers (2026) **S**
